Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion-Reference-Cited by-同舟云学术

Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion

Published:2013-07-19 Issue:1 Volume:163 Page:47-54
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Puiggros Anna,Delgado Julio¹,Rodriguez-Vicente Ana²,Collado Rosa³,Aventín Anna⁴,Luño Elisa⁵,Grau Javier⁶,Hernandez José Ángel⁷,Marugán Isabel⁸,Ardanaz Maite⁹,González Teresa¹⁰,Valiente Alberto¹¹,Osma Mar¹²,Calasanz Maria José¹³,Sanzo Carmen⁵,Carrió Ana¹,Ortega Margarita¹⁴,Santacruz Rodrigo¹,Abrisqueta Pau¹⁴,Abella Eugènia¹⁵,Bosch Francesc¹⁴,Carbonell Félix³,Solé Francesc¹⁶,Hernández Jesús Maria²,Espinet Blanca,

Affiliation:

1. Secció d'Hematopatologia; Hospital Clínic; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS); Universitat de Barcelona; Barcelona; Spain

2. Servicio de Hematologia; Hospital Universitario de Salamanca; IBSAL; IBMCC; Centro de Investigación del Cáncer; Universidad de Salamanca; CSIC; Salamanca; Spain

3. Servicio de Hematología; Consorcio Hospital General Universitario; Valencia; Spain

4. Servicio de Hematología; Hospital Sant Pau; Barcelona; Spain

5. Servicio de Hematología; Hospital Universitario Central de Asturias; Oviedo; Spain

6. Servei d'Hematologia; Institut Català d'Oncologia-Hospital Universitari Germans Trias i Pujol; IJC; Badalona; Spain

7. Servicio de Hematología; Hospital Universitario Infanta Leonor; Madrid; Spain

8. Servicio de Hematología y Oncología Médica; Hospital Clínico Universitario; Valencia; Spain

9. Servicio de Hematología; Hospital Txagorritxu; Vitoria; Spain

10. Fundación Pública Galega de Medicina Xenómica; Santiago de Compostela; Spain

11. Servicios de Genética y Hematología; Complejo Hospitalario de Navarra; Pamplona; Spain

12. Servicio de Hematología; Hospital Universitario Morales Meseguer; Murcia; Spain

13. Departamento de Genética; Servicio de Citogenética; Universidad de Navarra; Pamplona; Spain

14. Laboratorio de Citogenética y Servicio de Hematología; Hospital Vall d'Hebron; Barcelona; Spain

15. Laboratori de Citogenètica Molecular; Laboratori de Citologia Hematològica; Servei de Patologia; Hospital del Mar; Barcelona; Spain

16. Institut de Recerca contra la Leucèmia Josep Carreras; Badalona; Spain

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12479/fullpdf

Reference24 articles.

1. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia;Calin;Proceedings of the National Academy of Sciences of the United States of America,2002

2. Biallelic deletion 13q14.3 in patients with chronic lymphocytic leukemia: Cytogenetic, FISH and clinical studies;Chena;European Journal of Haematology,2008

3. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia;Dal Bo;Genes, Chromosomes & Cancer,2011

4. The use of tetradecanoylphorbol acetate-stimulated peripheral blood cells enhances the prognostic value of interphase fluorescence in situ hybridization in patients with chronic lymphocytic leukemia;Delgado;Genes, Chromosomes & Cancer,2010

5. Chromosome anomalies detected by interphase fluorescence in situ hybridization: Correlation with significant biological features of B-cell chronic lymphocytic leukaemia;Dewald;British Journal of Haematology,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions;Cancer Genetics;2023-04

2. Structure and prognostic signifi cance of 13q14 deletion in chronic lymphocytic leukemia;Russian journal of hematology and transfusiology;2022-04-11

3. Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?;Molecular Cytogenetics;2021-01-06

4. Precise determination of primary cytogenetic abnormalities provides added value for stratification of chronic lymphocytic leukemia patients;Neoplasma;2019

5. A higher percentage of cells with 13q deletion predicts worse outcome in Chinese patients with chronic lymphocytic leukemia carrying isolated 13q deletion;Annals of Hematology;2018-05-07